Shenzhen Hepalink Pharmaceutical Group Market Cap

Shenzhen Hepalink Pharmaceutical Group has a market cap or net worth of 13.60 billion as of January 3, 2025. Its market cap has decreased by -17.68% in one year.

Market Cap

13.60B

Enterprise Value

14.91B

Revenue

5.45B

Ranking

n/a

PE Ratio

n/a

Stock Price

10.33

Market Cap Chart

Since May 6, 2010, Shenzhen Hepalink Pharmaceutical Group's market cap has decreased from 70.09B to 13.60B, a decrease of -80.59%. That is a compound annual growth rate of -10.57%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	13.60B	-3.87%
Dec 31, 2024	14.15B	-7.78%
Dec 29, 2023	15.34B	-10.21%
Dec 30, 2022	17.09B	-25.00%
Dec 31, 2021	22.79B	-3.74%
Dec 31, 2020	23.67B	-2.72%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Mindray Bio-Medical Electronics	294.68B
Jiangsu Hengrui Medicine	282.07B
WuXi AppTec	150.16B
Zhangzhou Pientzehuang Pharmaceutical.,	123.98B
Aier Eye Hospital Group	116.12B
Shanghai United Imaging Healthcare	103.88B
Yunnan Baiyao Group Co.,Ltd	103.58B
Beijing Wantai Biological Pharmacy Enterprise	89.42B

Market Cap Rankings